These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
722 related articles for article (PubMed ID: 23624543)
21. [Significance of MICA antibody monitoring in management of acute and chronic rejection after renal transplantation]. Ding X; Jiao F; Wang X; Xue W; Tian P; Li Y; Tian X Nan Fang Yi Ke Da Xue Xue Bao; 2013 Oct; 33(10):1427-31. PubMed ID: 24144740 [TBL] [Abstract][Full Text] [Related]
22. Monitoring of circulating antibodies in a renal transplantation population: preliminary results. Rodríguez Ferrero ML; Arroyo D; Panizo N; Vicario JL; Balas A; Anaya F Transplant Proc; 2012 Nov; 44(9):2548-50. PubMed ID: 23146450 [TBL] [Abstract][Full Text] [Related]
24. Donor non-specific MICA antibodies in renal transplant recipients. Sapák M; Chreňová S; Tirpáková J; Žilinská Z; Ďurmanová V; Shawkatová I; Jakuš V; Kuba D; Buc M Immunobiology; 2014 Feb; 219(2):109-12. PubMed ID: 24054943 [TBL] [Abstract][Full Text] [Related]
25. [Anti-MICA antibodies: risk factors for sensitization and the impact on renal transplantation outcomes]. Yu LX; Wang G; Fu SJ; Xiao LL; Xu J; DU CF Nan Fang Yi Ke Da Xue Xue Bao; 2011 Apr; 31(4):615-8. PubMed ID: 21515454 [TBL] [Abstract][Full Text] [Related]
26. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens. Dignan R; O'Brien M; Hogan P; Thornton A; Fowler K; Byrne D; Stephens F; Harrocks S J Heart Valve Dis; 2003 May; 12(3):382-90; discussion 390-1. PubMed ID: 12803340 [TBL] [Abstract][Full Text] [Related]
27. Serum flow cytometric C1q binding antibody analysis of renal recipients with low levels of sensitization. Ata P; Canbakan M; Kara M; Özel L; Ünal E; Titiz Mİ Transplant Proc; 2012; 44(6):1652-5. PubMed ID: 22841237 [TBL] [Abstract][Full Text] [Related]
28. Kidney graft recipients with pretransplantation HLA CLASS I antibodies and high soluble CD30 are at high risk for graft loss. Rodríguez LM; París SC; Arbeláez M; Cotes JM; Süsal C; Torres Y; García LF Hum Immunol; 2007 Aug; 68(8):652-60. PubMed ID: 17678719 [TBL] [Abstract][Full Text] [Related]
29. Complement-fixing antibodies against denatured HLA and MICA antigens are associated with antibody mediated rejection. Cai J; Terasaki PI; Zhu D; Lachmann N; Schönemann C; Everly MJ; Qing X Exp Mol Pathol; 2016 Feb; 100(1):45-50. PubMed ID: 26615783 [TBL] [Abstract][Full Text] [Related]
30. Detection of anti-MICA antibodies in patients awaiting kidney transplantation, during the post-transplant course, and in eluates from rejected kidney allografts by Luminex flow cytometry. Zou Y; Heinemann FM; Grosse-Wilde H; Sireci G; Wang Z; Lavingia B; Stastny P Hum Immunol; 2006 Mar; 67(3):230-7. PubMed ID: 16698447 [TBL] [Abstract][Full Text] [Related]
31. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation. Li X; Ishida H; Yamaguchi Y; Tanabe K Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618 [TBL] [Abstract][Full Text] [Related]
32. The effect of anti-human leukocyte antigen, anti-major histocompatibility complex class 1 chain-related antigen a, and anti-glutathione transferase-T1 antibodies on the long-term survival of renal allograft. Akgul SU; Oğuz FS; Çalışkan Y; Kekik C; Çağatay P; Türkmen A; Nane I; Aydın F; Temurhan S Transplant Proc; 2013 Apr; 45(3):890-4. PubMed ID: 23622580 [TBL] [Abstract][Full Text] [Related]
33. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation. Vu LT; Baxter-Lowe LA; Garcia J; McEnhill M; Summers P; Hirose R; Lee M; Stock PG Arch Surg; 2011 Jul; 146(7):824-9. PubMed ID: 21768429 [TBL] [Abstract][Full Text] [Related]
34. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients. George JF; Kirklin JK; Shroyer TW; Naftel DC; Bourge RC; McGiffin DC; White-Williams C; Noreuil T J Heart Lung Transplant; 1995; 14(5):856-64. PubMed ID: 8800720 [TBL] [Abstract][Full Text] [Related]
35. Immunological monitoring of posttransplant allograft sensitization following living related donor renal transplantation. Panigrahi A; Deka R; Bhowmik D; Tiwari SC; Mehra NK Transplant Proc; 2004 Jun; 36(5):1336-9. PubMed ID: 15251326 [TBL] [Abstract][Full Text] [Related]
37. Pre- and posttransplantation allosensitization in heart allograft recipients: major impact of de novo alloantibody production on allograft survival. Ho EK; Vlad G; Vasilescu ER; de la Torre L; Colovai AI; Burke E; Deng M; Schwartz J; Marboe C; Mancini D; Opelz G; Suciu-Foca N Hum Immunol; 2011 Jan; 72(1):5-10. PubMed ID: 20971146 [TBL] [Abstract][Full Text] [Related]
38. Role of human leukocyte antigen, donor-specific antibodies, and their impact in renal transplantation. Thiyagarajan UM; Bagul A; Frost J; Horsburgh T; Nicholson ML Transplant Proc; 2012 Jun; 44(5):1231-5. PubMed ID: 22663991 [TBL] [Abstract][Full Text] [Related]